Twenty years after Europe licensed a testosterone treatment for women, the US Food and Drug Administration has asked for evidence on a use it has never approved. A new unreviewed study, meanwhile, raises questions about heart safety. In July 2006, the European...
Elinzanetant, a non-hormonal pill that acts on the brain’s temperature control centre, is under fast-track review in the US for hot flushes caused by breast cancer therapy. Regulators in the UK, the EU, Switzerland and Canada have already approved it for this...
Anxiety and depression become more common for some women during the menopause transition, and many don’t link the two. Guidelines from NICE and FIGO now give women a clear basis to ask for mood to be assessed, and Australia has funded a GP check that includes...
Women who had entered the menopausal transition by the age of 46 were 44% more likely to report clinically significant anxiety, a Finnish study of more than 2,600 women shows. Menopause guidance in England already asks clinicians to address mood, and women can ask for...
Illinois has made it unlawful to discriminate against workers because of perimenopause or menopause. From 1 January 2027, employers with four or more staff must offer reasonable accommodations, and workers will have a clear route to ask for them. Hot flushes, broken...
